Contact
searchSearch
HMP Global

Volume 1 - Issue 3 - September 2021

September 2021 JCLI, Volume 1, Issue 3: Table of Contents and Whole Issue PDF
03/07/2022
Table of Contents and Whole Issue PDF
Table of Contents and Whole Issue PDF
Table of Contents and Whole...
03/07/2022
Journal of Critical Limb Ischemia
Original Contribution
Outcomes Among Patients With Chronic Critical Limb Ischemia With No Revascularization Option: Systematic Review and Meta-Analysis
09/28/2021
M. Imran Ghare, MD; Cody Pietras, BA; Daniela Tirziu, PhD; Helen Parise, ScD; Roseann White, PhD; S. Elissa Altin, MD; Sameer Nagpal, MD; Alexandra J. Lansky, MD
Two prespecified literature searches were conducted via Ovid utilizing the following databases: MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews (CDSR). We selected studies reporting amputation-free survival (AFS) in patients with...
Two prespecified literature searches were conducted via Ovid utilizing the following databases: MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews (CDSR). We selected studies reporting amputation-free survival (AFS) in patients with...
Two prespecified literature...
09/28/2021
Journal of Critical Limb Ischemia
Editorial/Commentary
When “No Options” is No Longer an Option: Moving the Needle Forward in Advanced Stage Critical Limb Ischemia
09/28/2021
Nicholas J. Reid, BSc; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
An editorial commentary on Ghare et al's "Outcomes among patients with chronic critical limb ischemia with no revascularization option: systematic review and meta-analysis."
An editorial commentary on Ghare et al's "Outcomes among patients with chronic critical limb ischemia with no revascularization option: systematic review and meta-analysis."
An editorial commentary on Ghare...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution
Chronic Total Occlusions: Association Between Characteristics and Mid-Term Outcomes in Critical Limb Ischemia
09/28/2021
Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab, MD, FACC, FSCAI; Theresa McGoff, BSN; Sara Finton, BSN; George L. Adams, MD, MHS, MBA, FACC, FSCAI; J. Randall Mullins, MD; Michael R. Jaff, MD, DO; Farhan Khawaja, MD; Philip P. Goodney, MD; Gabor Matos, MD; M. Laiq Raja, MD; Michael Sumners, DO
Despite medical advancements, PAD and CLI continue to increase globally. Treatment for PAD/CLI varies widely and patients with CTOs may be more challenging to treat, requiring specialized crossing techniques and modalities. The objective of...
Despite medical advancements, PAD and CLI continue to increase globally. Treatment for PAD/CLI varies widely and patients with CTOs may be more challenging to treat, requiring specialized crossing techniques and modalities. The objective of...
Despite medical advancements,...
09/28/2021
Journal of Critical Limb Ischemia
Editorial/Commentary
Novel Chronic Total Occlusion Scoring System in Predicting Outcome: Is it Ready for PRIME Time?
09/28/2021
Terrence Chi Hong Hui, MBBS, MRCSI, FRCR, MMed; Uei Pua, MD
Editorial commentary on Mustapha et al's "Chronic total occlusions: association between characteristics and long-term outcomes in critical limb ischemia."
Editorial commentary on Mustapha et al's "Chronic total occlusions: association between characteristics and long-term outcomes in critical limb ischemia."
Editorial commentary on Mustapha...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution
Comparison Between Intra-Arterial Carbon Dioxide and Iodinated Contrast Agent Injections in Patients With Lower-Limb Peripheral Arterial Diseases and Mild-to-Moderate Renal Dysfunction: A Randomized Controlled Trial
09/28/2021
Omid Shafe, MD; Ehsan Samiee, MD; Jamal Moosavi, MD; Bahram Mohebbi, MD; Amir A. Fakhrabadi, MD; Hooman Bakhshandeh, MD, PhD; Batoul Naghavi, MD, MPH; Reza Tahivili; Saeed Cheraghi; Parham Sadeghipour, MD
This randomized, controlled trial was designed to compare the rate of postangiographic contrast-induced nephropathy between the intra-arterial injections of carbon dioxide and the iodinated contrast agent.
This randomized, controlled trial was designed to compare the rate of postangiographic contrast-induced nephropathy between the intra-arterial injections of carbon dioxide and the iodinated contrast agent.
This randomized, controlled...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution
Predictors of Long-Term Mortality in Patients Undergoing Major or Minor Lower-Extremity Amputations
09/28/2021
Joji J. Varghese, MD, FACC, FSCAI; Bailey Ann Estes MSN, AGNP-C, RN-BC, RNFA, CNOR, RCIS; Brad J. Martinsen, PhD; Zsuzsanna Igyarto, PhD; Srihari S. Naidu MD, MSCAI; Fadi Saab, MD, FACC, FSCAI; Jihad A. Mustapha, MD, FACC, FSCAI
Amputation as the initial treatment of choice remains prevalent despite advances in revascularization techniques and medical therapy. We evaluated the 7-year mortality of patients undergoing major and minor lower-extremity amputations and...
Amputation as the initial treatment of choice remains prevalent despite advances in revascularization techniques and medical therapy. We evaluated the 7-year mortality of patients undergoing major and minor lower-extremity amputations and...
Amputation as the initial...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution, Review
Orbital Atherectomy Treatment of Peripheral Artery Disease and Critical Limb Ischemia
09/28/2021
Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab, MD, FACC, FSCAI; Brad J. Martinsen, PhD; Ann N. Behrens, BS; Miguel Montero-Baker, MD; Bret N. Wiechmann, MD, FSIR, FAHA; Eric C. Scott, MD; David G. Armstrong, DPM, MD, PhD; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; George L. Adams, MD, MHS, MBA, FACC, FSCAI
We review here the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
We review here the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
We review here the mechanism of...
09/28/2021
Journal of Critical Limb Ischemia

News

News
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k)...
09/08/2025
Journal of Critical Limb Ischemia
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/14/2025
Jos C. van den Berg, MD, PhD
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional...
08/14/2025
Journal of Critical Limb Ischemia
DR NEVILLE
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/14/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/14/2025
Journal of Critical Limb Ischemia
AMBITION BTK TRIAL FOR CLTI
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
07/24/2025
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective,...
07/24/2025
Vascular Disease Management

Stay in the Know

Journal of Critical Limb Ischemia Newsletter

September 2021 Volume 1 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use